Cargando…
S288: DIFFERENTIAL RECOVERY OF MACROPHAGE IRON DEFICIENCY BY ORAL IRON FORMULATIONS DETERMINES CELL INFLAMMATORY ACTIVATION IN ANEMIC CONDITIONS
Autores principales: | Antypiuk, Ada, Sharma, Richa, Brilli, Elisa, Tarantino, Germano, Vinchi, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428353/ http://dx.doi.org/10.1097/01.HS9.0000968064.81887.8d |
Ejemplares similares
-
S286: TARGETING CONDITIONING-ELICITED NON-TRANSFERRIN-BOUND IRON BY TMPRSS6 SILENCING IMPROVES BONE MARROW TRANSPLANT OUTCOME
por: Antypiuk, Ada, et al.
Publicado: (2023) -
Sucrosomial(®) Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency
por: Gómez-Ramírez, Susana, et al.
Publicado: (2023) -
Sucrosomial(®) Iron: A New Generation Iron for Improving Oral Supplementation
por: Gómez-Ramírez, Susana, et al.
Publicado: (2018) -
Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages
por: Patino, Edwin, et al.
Publicado: (2023) -
Iron deficiency: lessons from anemic mice.
por: Andrews, N. C.
Publicado: (1997)